Skip to main content
. 2017 Jun 14;7:3471. doi: 10.1038/s41598-017-02992-7

Figure 2.

Figure 2

Comparison between neoadjuvant (n = 4984) and no-neoadjuvant groups (n = 4984) in the propensity score matched cohort. (A) Kaplan-Meier curves for cancer-specific survival. (B) HR of every clinical covariate from Cox model. (C) Sensitivity analysis estimating the effect of unmeasured confounders on hazard ratio. Red star means significantly render treatment effect (the lower confidence bound of CI is larger than 1).